EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Glymphatic–Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers

Daniel Costea, Nicolaie Dobrin, Catalina-Ioana Tataru, Corneliu Toader, Matei Șerban, Răzvan-Adrian Covache-Busuioc, Octavian Munteanu, Ionut Bogdan Diaconescu

International Journal of Molecular Sciences · 30.10.2025 · 26 (21) · 10546

DOI: 10.3390/ijms262110546 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2025. Verfasst von Daniel Costea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Puls Med Association, 051885 Bucharest, Romania. Hauptthemen laut MEDLINE: Glymphatic System, Aquaporin 4, Brain, Neurodegenerative Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of brain clearance failure as a precursor to a large variety of neurodegenerative diseases has shifted fluid dynamics from a secondary to a tertiary target of brain health. The identification of the glymphatic system, detailing cerebrospinal fluid entry along perivascular spaces and exit via perivenous and meningeal lymphatic pathways, provided a challenge to previous diffusion models and established aquaporin-4–dependent astroglial polarity as a governing principle of solute transport. Multiple lines of evidence now support a coupled glymphatic–venous axis, wherein vasomotion, venous outflow, and lymphatic drainage are functionally interrelated. Failure of any axis will cascade and affect the entire axis, linking venous congestion, aquaporin-4 disassembly, and meningeal lymphatic failure to protein aggregation, neuroinflammation, edema, and intracranial hypertension. Specific lines of evidence from diffusion tensor imaging along vascular spaces, clearance MRI, and multi-omic biomarkers can provide a measure of transport. Therapeutic strategies are rapidly advancing from experimental strategies to translational approval, including behavioral optimization, closed-loop sleep stimulation, vascular and lymphatic therapies, focused ultrasound, pharmacological polarity recoupling, and regenerative bioengineering. Novel computational approaches, such as digital twin dynamic modeling and adaptive trial designs, suggest that clearance measures may serve as endpoints to be approved by the FDA. This review is intended to bridge relevant mechanistic and translational reviews, focusing on impaired clearance as an exploitable systems defect rather than an incapacitating secondary effect. Improving our understanding of the glymphatic-venous axis Injury may lead to future target strategies that advance cognitive resilience, alleviate disease burden, and improve quality of life. By clarifying the glymphatic–venous axis, we provide a mechanistic link between impaired interstitial clearance and the pathological accumulation of amyloid-β, tau, and α-synuclein in neurodegenerative diseases. The repair of aquaporin-4 polarity, venous compliance, and lymphatic drainage might therefore open new avenues for the diagnosis and treatment of Alzheimer’s and Parkinson’s disease, supplying both biomarkers of disease progression and new targets for early intervention. These translational implications not only locate clearance failure as an epiphenomenon of neurodegeneration but, more importantly, as a modifiable driver of the course of neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glymphatic SystemAquaporin 4BrainNeurodegenerative DiseasesHumansBiomarkersAnimalsPrecision Medicine

Stichwörter der Autor:innen

Aquaporin-4biomarkersbrain clearanceglymphatic systemneurodegenerationvenous congestion

Substanzen

Aquaporin 4Biomarkers

Autor:innen und Institutionen

  • Puls Med Association, 051885 Bucharest, Romania.
  • Department of Neurosurgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • "Nicolae Oblu" Clinical Hospital, 700309 Iasi, Romania.
  • Clinical Department of Ophthalmology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Ophthalmology, Clinical Hospital for Ophthalmological Emergencies, 010464 Bucharest, Romania.
  • Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Zitieren

APA

Costea, D., Dobrin, N., Tataru, C. I., Toader, C., Șerban, M., Covache-Busuioc, R. A., Munteanu, O., & Diaconescu, I. B. (2025). The Glymphatic–Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers. International Journal of Molecular Sciences, 26(21), 10546. https://doi.org/10.3390/ijms262110546

Vancouver

Costea D, Dobrin N, Tataru CI, Toader C, Șerban M, Covache-Busuioc RA, et al. The Glymphatic–Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers. International Journal of Molecular Sciences. 2025;26(21):10546. doi:10.3390/ijms262110546

BibTeX
@article{Costea2025,
  author = {Costea, Daniel and Dobrin, Nicolaie and Tataru, Catalina-Ioana and Toader, Corneliu and Șerban, Matei and Covache-Busuioc, Răzvan-Adrian and Munteanu, Octavian and Diaconescu, Ionut Bogdan},
  title = {The Glymphatic–Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10546},
  doi = {10.3390/ijms262110546}
}
Kostenlos starten →